1. Home
  2. DAIO vs INTS Comparison

DAIO vs INTS Comparison

Compare DAIO & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAIO
  • INTS
  • Stock Information
  • Founded
  • DAIO 1969
  • INTS 2012
  • Country
  • DAIO United States
  • INTS United States
  • Employees
  • DAIO N/A
  • INTS N/A
  • Industry
  • DAIO Electrical Products
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAIO Industrials
  • INTS Health Care
  • Exchange
  • DAIO Nasdaq
  • INTS Nasdaq
  • Market Cap
  • DAIO 26.9M
  • INTS 30.8M
  • IPO Year
  • DAIO N/A
  • INTS 2023
  • Fundamental
  • Price
  • DAIO $2.45
  • INTS $2.00
  • Analyst Decision
  • DAIO Strong Buy
  • INTS Strong Buy
  • Analyst Count
  • DAIO 1
  • INTS 3
  • Target Price
  • DAIO $4.00
  • INTS $8.50
  • AVG Volume (30 Days)
  • DAIO 11.4K
  • INTS 37.8K
  • Earning Date
  • DAIO 04-24-2025
  • INTS 03-13-2025
  • Dividend Yield
  • DAIO N/A
  • INTS N/A
  • EPS Growth
  • DAIO N/A
  • INTS N/A
  • EPS
  • DAIO N/A
  • INTS N/A
  • Revenue
  • DAIO $21,769,000.00
  • INTS N/A
  • Revenue This Year
  • DAIO $4.86
  • INTS N/A
  • Revenue Next Year
  • DAIO N/A
  • INTS N/A
  • P/E Ratio
  • DAIO N/A
  • INTS N/A
  • Revenue Growth
  • DAIO N/A
  • INTS N/A
  • 52 Week Low
  • DAIO $2.29
  • INTS $1.50
  • 52 Week High
  • DAIO $3.99
  • INTS $5.28
  • Technical
  • Relative Strength Index (RSI)
  • DAIO 42.08
  • INTS 43.39
  • Support Level
  • DAIO $2.36
  • INTS $1.88
  • Resistance Level
  • DAIO $2.53
  • INTS $2.18
  • Average True Range (ATR)
  • DAIO 0.11
  • INTS 0.21
  • MACD
  • DAIO 0.02
  • INTS -0.01
  • Stochastic Oscillator
  • DAIO 52.38
  • INTS 31.51

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in United States, Europe and Rest of the world.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: